Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Полное описание

Библиографические подробности

Главные авторы:	Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2023-07-01
Серии:	Frontiers in Immunology
Предметы:	multiple sclerosis cladribine biomarkers omics bioinformatics
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!